[抗腫瘍免疫反応におけるCD8+ T細胞]
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。マルチオミックスの最近の進歩は,CD8+T細胞のダイナミクスを明らかにし,効果的ながん免疫療法に不可欠です. 先駆性T細胞 (Tpex) とその相互作用を理解すると,より優れたがんワクチンと治療のための抗腫瘍反応が強化されます.
科学分野
- 免疫学
- 腫瘍学
- ゲノミクス
背景
- 伝統的ながんワクチンは有効性が限られている.
- 免疫チェックポイント阻害剤 (ICI) は,様々ながんにおいて高い治療の可能性を示しています.
- マルチオミクス技術は,免疫細胞のダイナミクスの詳細な単細胞分析を可能にします.
研究 の 目的
- がん免疫療法におけるCD8+T細胞のインビボ動態を解明する.
- 腫瘍の微小環境内の重要な免疫細胞サブセットと相互作用を特定する.
- 新種のがんワクチンや 併用免疫療法戦略の開発に役立つ.
主な方法
- 単細胞RNAシーケンシング (scRNA-seq)
- 空間トランスクリプトミクス
- 多色免疫染色
主要な成果
- CD8+ T細胞は抗腫瘍免疫の中心であり,様々なサブセットが特定されています.
- 先駆性T細胞 (Tpex) / 幹細胞記憶T細胞 (TSCM) は,腫瘍およびリンパ節内の重要なICI標的である.
- CD4+ T細胞,デンドリット細胞,B細胞,CD8+ T細胞の相互作用は,細胞毒性CD8+エフェクターT細胞を生成するために不可欠である.
結論
- 患者特有のCD8+T細胞動態の正確な理解は,免疫療法を強化するために不可欠です.
- Tpex/TSCM細胞を標的とし,免疫細胞の相互作用を最適化することで,抗腫瘍効果が改善されます.
- この知識はワクチン療法,結合免疫療法,細胞免疫療法の開発を進めるでしょう.
関連する概念動画
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Overview
The cell-mediated immune system is the host’s primary response against invasive bacteria and viruses that cause intracellular infections. It is also essential for fighting against and destroying cancer cells. Furthermore, the cell-mediated immune system plays a role in the rejection of organ transplants or graft tissue.
The Innate Immune System Activates the Adaptive Immune System
Phagocytic cells of the innate immune system, such as macrophages or dendritic cells, are the...